Carlos E. Vigil
Impact in
- Hematology top 2%
- Acute Myeloid Leukemia Research
- Chronic Myeloid Leukemia Treatments
- Hematopoietic Stem Cell Transplantation
- Genetics top 10%
- Myeloproliferative Neoplasms: Diagnosis and Treatment
Papers in
- Hematology 30
- Acute Myeloid Leukemia Research 28
- Chronic Myeloid Leukemia Treatments 9
- Multiple Myeloma Research and Treatments 5
-
- Histone Deacetylase Inhibitors Research 6
- Protein Degradation and Inhibitors 5
- Co-authors
- Eunice S. Wang (12 shared papers)Catherine Chodkiewicz (1 shared paper)J.M. Ortega (1 shared paper)Grerk Sutamtewagul (1 shared paper)Meir Wetzler (8 shared papers)Elizabeth A. Griffiths (6 shared papers)Joseph A. Pinto (6 shared papers)Henry Gómez (5 shared papers)
- Journals
- Blood (15 papers)Journal of Clinical Oncology (9 papers)Leukemia Research (3 papers)Clinical Breast Cancer (1 paper)Biology of Blood and Marrow Transplantation (1 paper)
- Partner nations
- United StatesGermanyPeru
In The Last Decade
Carlos E. Vigil
46 papers receiving 778 citations
Peers
Comparison fields: 5 of 68
- Hematology 322
- Genetics 110
- Oncology 197
- Cancer Research 96
- Pathology and Forensic Medicine 91
Countries citing papers authored by Carlos E. Vigil
This map shows the geographic impact of Carlos E. Vigil's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carlos E. Vigil with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carlos E. Vigil more than expected).
Fields of papers citing papers by Carlos E. Vigil
This network shows the impact of papers produced by Carlos E. Vigil. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carlos E. Vigil. The network helps show where Carlos E. Vigil may publish in the future.
Co-authors
The 25 scholars most cited alongside Carlos E. Vigil, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 47 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 114 | |
| 2 | 2011 | 107 | |
| 3 | 2010 | 91 | |
| 4 | 2015 | 56 | |
| 5 | 2013 | 56 | |
| 6 | 2010 | 48 | |
| 7 | 2019 | 32 | |
| 8 | 2018 | 30 | |
| 9 | 2024 | 28 | |
| 10 | 2010 | 27 | |
| 11 | 2015 | 26 | |
| 12 | 2011 | 19 | |
| 13 | 2017 | 16 | |
| 14 | 2019 | 14 | |
| 15 | Aves argentinas y sudamericanas | 1973 | 13 |
| 16 | 2018 | 11 | |
| 17 | 2010 | 10 | |
| 18 | 2018 | 7 | |
| 19 | 2024 | 7 | |
| 20 | 2018 | 7 |
About Carlos E. Vigil
Carlos E. Vigil is a scholar working on Hematology, Molecular Biology, Genetics, Immunology and Oncology, having authored 47 papers that have together received 801 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (28 papers), Chronic Myeloid Leukemia Treatments (9 papers), Histone Deacetylase Inhibitors Research (6 papers), Protein Degradation and Inhibitors (5 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (5 papers), Multiple Myeloma Research and Treatments (5 papers), Chronic Lymphocytic Leukemia Research (5 papers) and CAR-T cell therapy research (4 papers). The work is most often cited by research in Hematology (322 citations), Genetics (110 citations), Oncology (197 citations), Cancer Research (96 citations) and Pathology and Forensic Medicine (91 citations). Carlos E. Vigil has collaborated with scholars based in United States, Germany and Peru. Frequent co-authors include Eunice S. Wang, Catherine Chodkiewicz, J.M. Ortega, Grerk Sutamtewagul, Meir Wetzler, Elizabeth A. Griffiths, Joseph A. Pinto, Henry Gómez, Carlos Vallejos and Guillermo Garcia‐Manero. Their work appears in journals such as Blood, Journal of Clinical Oncology, Leukemia Research, Clinical Breast Cancer and Biology of Blood and Marrow Transplantation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.